# Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products, Division 2

Extent: E+W+S+N.I.

If possible, the immune mechanism (cell-mediated/humoral, local/general classes of immunoglobulin) which is initiated after the administration of the immunological veterinary medicinal product to target animals by the recommended route of administration shall be specified and documented.

---
Source: https://www.legislation.gov.uk/eudr/2001/82/annex/I/title/II/part/4/chapter/II/division/B/division/2 (the official version)
Page: https://openlegislation.uk/eu-directive-2001-82/annex-I/title-II/part-4/chapter-II/division-B/division-2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.